SciELO - Scientific Electronic Library Online

 
vol.63Selective bromination of 4-chloro-1-indanone and synthesis of (4-chloro-2, 3-dihydro-1H-indene-2-yl)methanamineImidazole-based vanadium complexes as haloperoxidase models for oxidation reactions índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • En proceso de indezaciónSimilares en Google

Compartir


South African Journal of Chemistry

versión On-line ISSN 1996-840X
versión impresa ISSN 0379-4350

S.Afr.j.chem. (Online) vol.63  Durban  2010

 

RESEARCH ARTICLE

 

The synthesis of substituted piperazine-cholesterol conjugates for use as components of nucleic acid transfection lipoplexes*

 

 

Rafique Ul IslamI, II; Myron M. JohnsonI, II; Raushaan MohammedI; Justin HeanII; Patrick ArbuthnotII; Charles B. de KoningI, **; Willem A.L. van OtterloI, **

IMolecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Private Bag 3, WITS 2050, South Africa
IIAntiviral Gene Therapy Research Unit, School of Pathology, University of the Witwatersrand Medical School, Private Bag 3, WITS 2050, South Africa

 

 


ABSTRACT

A small library of cholesterol-piperazine conjugates were synthesized by the reaction of cholesteryl chloroformate with a set of substituted piperazines in dichloromethane at room temperature. The conjugates, all obtained in good to excellent yields, were synthesized to be key components of nucleic acid transfection lipoplexes.

Keywords: Piperazine, cholesterol, conjugates, transfection, cationic lipoplexes


 

 

Full text available only in PDF format.

 

Acknowledgements

This material is based upon work supported financially by the National Research Foundation (NRF GUN 68339, 65495, 2053652 and IRDP of the NRF), Pretoria. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the NRF does not accept any liability in regard thereto. This work was also supported by funding under the Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004-005276), from CANSA, ESASTAP the South African Poliomyelitis Research Foundation and by the University of the Witwatersrand. We also gratefully acknowledge Mr R. Mampa for providing the NMR service and Dr A. Dinsmore and Mrs M. Ferreira for supplying some LRMS spectroscopy results. Ms J. Schneider and Ms M. Ismail from the Mass Spectroscopy Service, University of Dortmund and Max Planck Institute for Molecular Physiology, Dortmund, Germany, are thanked for performing the HRMS on the compounds 6a-q, 7, 9 and 11.

 

References and Notes

1 (a) M.D. Brown, A.G. Schätzlein, I.F. Uchegbu, Int. J. Pharm. 2001, 229, 1-21.         [ Links ] (b) A. Hirko, F. Tang, J.A. Hughes, Curr. Med. Chem. 2003, 10, 1185-1193.         [ Links ] (c) M.A. Ilies, W.A. Seitz, A.T. Balaban, Curr. Pharm. Des. 2002, 8, 2441-2473.         [ Links ] (d) V.V Kumar, R.S. Singh, A. Chaudhuri, Curr. Med. Chem. 2003, 10, 1297-1306.         [ Links ] (e) D. Liu, T. Ren, X. Gao, Curr. Med. Chem. 2003,10, 1307-1315.         [ Links ] (f) B. Martin, M. Sainlos, A. Aissaoui, N. Oudrhiri, M. Hauchecorne, J.-P. Vigneron, J.-M. Lehn, P. Lehn, Curr. Pharm. Des. 2005, 11, 375-394.         [ Links ] (g) N.M. Rao, V Gopal, Expert Opin. Ther. Pat. 2006, 16, 825-844.         [ Links ] (h) L.Wasungu, D. Hoekstra, J. Controlled Release 2006, 116, 255-264.         [ Links ] (i) S. Zhang, Y. Xu, B. Wang, W. Qiao, D. Liu, Z. Li, J. Controlled Release 2004, 100, 165-180.         [ Links ] (j) P.P Karmali, A. Chaudhuri, Med. Res. Rev. 2007, 27, 696-722.         [ Links ]

2 E.R. Lee, J. Marshall, C.S. Siegel, C. Jiang, N.S. Yew, M.R. Nichols, J.B. Nietupski, R.J. Ziegler, M.B. Lane, K.X. Wang, N.C. Wan, R.K. Scheule, D.J. Harris, A.E. Smith, S.H. Cheng, Hum. Gene Ther. 1996, 7, 1701-1717.         [ Links ]

3 D. Moradpour, J.I. Schauer, V R. Zurawski, Jr, J.R. Wands, R.H. Boutin, Biochem. Biophys. Res. Commun. 1996, 221, 82-88.         [ Links ]

4 H. Gao, K. M. Hui, Gene Ther. 2001, 8, 855-863.         [ Links ]

5 (a) R. Ul Islam, J. Hean, W.A.L. van Otterlo, C.B. de Koning, P. Arbuthnot, Bioorg. Med. Chem. Lett. 2009,19, 100-103.         [ Links ] (b) J. Hean, C. Crowther, A. Ely, R. Ul Islam, S. Barichievy, K. Bloom, M.S. Weinberg, W.A.L. van Otterlo, C.B. de Koning, F. Salazar, P. Marion, E.B. Roesch, M. LeMaitre, P. Herdewijn, P. Arbuthnot, Artificial DNA: PNA & XNA, 2010, 1, 17-26.         [ Links ]

6 (a) Aspects of this research were outlined in a poster presented at the South African Chemical Institute 11th Frank Warren Conference in Pietermaritzburg in January 2010, 'The Synthesis of Cholesterol Based Cationic Lipids', M.M. Johnson, P. Arbuthnot, C.B. de Koning, J. Hean; W.A.L. van Otterlo. (b) The experimental work described in this paper was performed by R. Ul Islam (postdoctoral fellow), M.M. Johnson (MSc) and R. Mohammed (BSc).

7 For reviews on cross-metathesis see: (a) S.J. Connon, S. Blechert, Angew. Chem., Int. Ed. 2003, 42, 1900-1923.         [ Links ] (b) J.D. Waetzig P.R. Hanson, Chemtracts 2006,19, 157-167.         [ Links ] For recent work from our group on ruthenium-mediated ring-closing metathesis see: (c) G.L. Morgans, E.L. Ngidi, L.G. Madeley, S.D. Khanye, J.P. Michael, C.B. de Koning, W.A.L. van Otterlo, Tetrahedron 2009, 65, 10650-10659.         [ Links ] (d) E.M. Coyanis, J.-L. Panayides, M.A. Fernandes, C.B. de Koning, W.A.L. van Otterlo, J. Organomet. Chem. 2006, 691, 5222-5239.         [ Links ] (e) J.-L. Panayides, R. Pathak, C.B. de Koning, W.A.L. van Otterlo, Eur. J. Org. Chem. 2007, 4953-4961.         [ Links ] (f) J.-L. Panayides, R. Pathak, H. Panagiotopoulos, H. Davids, M.A. Fernandes, C.B. de Koning, W.A.L. van Otterlo, Tetrahedron 2007,63, 4737-4747.         [ Links ]

8 A. Bajaj, P. Kondiah, S. Bhattacharya, J. Med. Chem. 2007, 50, 2432-2442.         [ Links ]

9 See the following examples: (a) M.A. Ilies, W.A. Seitz, B.H. Johnson, E.L. Ezell, A.L. Miller, E.B. Thompson, A.T. Balaban, J. Med. Chem. 2006,49, 3872-3887.         [ Links ] (b) M.V. Bogatian, V. Cimpeanu, C. Deleanu, A.C. Corbu, G. Bogatian, T.S. Balaban, Arkivoc, x, 2005, 272-284.         [ Links ] (c) M.A. Ilies, B.H. Johnson, F. Makori, A. Miller, W.A. Seitz, E.B. Thompson, A.T. Balaban, Arch. Biochem. Biophys. 2005, 435, 217-226 (d) M.         [ Links ] Scarzello, J. Smisterová, A. Wagenaar, M.C.A. Stuart, D. Hoekstra, J.B.F.N. Engberts, R. Hulst, J. Am. Chem. Soc. 2005, 127, 10420-10429.         [ Links ] (e) M.A. Ilies, W.A. Seitz, I. Ghiviriga, B.H. Johnson, A. Miller, E.B. Thompson, A.T. Balaban, J. Med. Chem. 2004,47, 3744-3754.         [ Links ] (f) R. Hulst, I. Muizebelt, P. Oosting, C. van der Pol, A. Wagenaar, J. Smisterová, E. Bulten, C. Driessen, D. Hoekstra, J.B.F.N. Engberts J. Eur. J. Org. Chem. 2004, 835-849.         [ Links ] (g) M.A. Ilies, W.A. Seitz, M.T. Caproiu, M. Wentz, R.E. Garfield, A.T. Balaban, Eur. J. Org. Chem. 2003, 2645-2655.         [ Links ] (h) D. Pijper, E. Bulten, J. Smisterová, A. Wagenaar, D. Hoekstra, J.B.F.N. Engberts, R. Hulst, Eur. J. Org. Chem. 2003, 4406-4412.         [ Links ] (i) A. Roosjen, J. Smisterová, C. Driessen, J.T. Anders, A. Wagenaar, D. Hoekstra, R. Hulst, J.B.F.N. Engberts, Eur.J.Org. Chem. 2002, 1271-1277.         [ Links ] (j) D.A. Medvedeva, M.A. Maslov, R.N. Serikov, N.G. Morozova, G.A. Serebrenikova, D.V. Sheglov, A.V. Latyshev, V.V. Vlassov, M.A. Zenkova, J. Med. Chem. 2009, 52, 6558-6568.         [ Links ]

 

 

Received 8 May 2010
Revised 25 June 2010
Accepted 6 July 2010

 

 

* This paper was submitted upon invitation to invited speakers (CdK) at the South African Chemical Institute's 11th Frank Warren Conference, January 2010, in Pietermaritzburg, KwaZulu-Natal, South Africa.
** To whom correspondence should be addressed. E-mail: de Koning (charles.dekoning@wits.ac.za) van Otterlo (willem.vanotterlo@wits.ac.za)

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons